1. Home
  2. LXRX vs PDX Comparison

LXRX vs PDX Comparison

Compare LXRX & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.60

Market Cap

996.7M

Sector

Health Care

ML Signal

HOLD

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$20.45

Market Cap

895.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXRX
PDX
Founded
1995
2019
Country
United States
NY
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
996.7M
895.0M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
LXRX
PDX
Price
$1.60
$20.45
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $4.55
N/A
AVG Volume (30 Days)
★ 2.6M
114.4K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
★ 4.95%
EPS Growth
★ 77.78
N/A
EPS
N/A
★ N/A
Revenue
★ $49,803,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 60.24
N/A
52 Week Low
$1.10
$18.47
52 Week High
$2.68
$22.59

Technical Indicators

Market Signals
Indicator
LXRX
PDX
Relative Strength Index (RSI) 34.71 45.15
Support Level $1.50 $19.98
Resistance Level $1.81 $21.85
Average True Range (ATR) 0.07 0.28
MACD -0.00 0.02
Stochastic Oscillator 27.20 52.29

Price Performance

Historical Comparison
LXRX
PDX

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

Share on Social Networks: